Vapotherm (VAPO)
(Delayed Data from OTC)
$1.25 USD
-0.01 (-0.51%)
Updated Apr 26, 2024 03:42 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Vapotherm, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 69 | 67 | 113 | 126 | 48 |
Cost Of Goods | 40 | 50 | 60 | 63 | 27 |
Gross Profit | 28 | 17 | 53 | 63 | 21 |
Selling & Adminstrative & Depr. & Amort Expenses | 67 | 118 | 110 | 106 | 69 |
Income After Depreciation & Amortization | -39 | -100 | -57 | -43 | -48 |
Non-Operating Income | 0 | -1 | 0 | -4 | 2 |
Interest Expense | 19 | 12 | 3 | 5 | 5 |
Pretax Income | -58 | -113 | -60 | -52 | -51 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -58 | -113 | -60 | -52 | -51 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -58 | -113 | -60 | -52 | -51 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -32 | -72 | -51 | -38 | -45 |
Depreciation & Amortization (Cash Flow) | 7 | 28 | 6 | 5 | 3 |
Income After Depreciation & Amortization | -39 | -100 | -57 | -43 | -48 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 6.04 | 3.34 | 3.24 | 2.98 | 2.33 |
Diluted EPS Before Non-Recurring Items | -9.44 | -26.80 | -18.48 | -15.92 | -21.92 |
Diluted Net EPS (GAAP) | -9.64 | -33.92 | -18.48 | -17.28 | -21.92 |
Fiscal Year end for Vapotherm, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 19.73 | 15.17 | 16.04 | 17.73 |
Cost Of Goods | NA | 10.54 | 9.15 | 9.18 | 11.52 |
Gross Profit | NA | 9.20 | 6.01 | 6.86 | 6.21 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 14.22 | 16.29 | 17.02 | 19.84 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -5.02 | -10.28 | -10.16 | -13.63 |
Non-Operating Income | NA | -0.15 | -0.01 | 0.04 | -0.13 |
Interest Expense | NA | 4.93 | 4.83 | 4.64 | 4.33 |
Pretax Income | NA | -10.11 | -15.11 | -14.76 | -18.08 |
Income Taxes | NA | 0.07 | 0.02 | 0.03 | 0.01 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -10.19 | -15.13 | -14.79 | -18.09 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -10.19 | -15.13 | -14.79 | -18.09 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 6.37 | 6.36 | 6.33 | 5.08 |
Diluted EPS Before Non-Recurring Items | NA | -1.60 | -2.26 | -2.32 | -3.60 |
Diluted Net EPS (GAAP) | NA | -1.34 | -2.38 | -2.32 | -3.60 |